ABBOTT LABORATORIES (ABT) Free cash flow 2016–2025
ABBOTT LABORATORIES (ABT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$7.4BFY2025 · since FY2016: $2.1B → $7.4B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $7.4B | +16.4% |
| FY2024 | $6.4B | +25.5% |
| FY2023 | $5.1B | -35.2% |
| FY2022 | $7.8B | -9.8% |
| FY2021 | $8.6B | +51.1% |
| FY2020 | $5.7B | +27.3% |
| FY2019 | $4.5B | -8.3% |
| FY2018 | $4.9B | +10.6% |
| FY2017 | $4.4B | +113.0% |
| FY2016 | $2.1B | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice